Back to News
Market Impact: 0.1
Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Board
Source: marketbeat.com
Management & Governance
Cybin (NASDAQ: HELP), operating as Helus Pharma, held its Annual General and Special Meeting, with shareholders considering resolutions on the auditor, board size, corporate name and director elections. The article provides no voting outcomes, financial results or operational updates, limiting expected market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
HELP0.00
More News
- Paraguay’s Santiago Pena under arrest, new president Pedro Alliana sworn in
- Fox wraps up its $22 billion Roku deal
- How Paraguay’s Ueno collapse is only its latest banking crisis
- Do not investigate Trump’s corporate allies until he leaves office
- Apollo-backed dental firm vVardis seeks up to $229 million in US IPO
- Trump Names Miller Chief of Staff as Tech Rebounds